SP
SIH Partners Portfolio holdings
AUM
$1.05B
This Quarter Return
+0.17%
1 Year Return
+21.73%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(-20%)
Cap. Flow
-$258M
Cap. Flow
% of AUM
-22.66%
Top 10 Holdings %
Top 10 Hldgs %
64.91%
Holding
282
New
168
Increased
28
Reduced
29
Closed
25
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$124M |
| 2 |
Stellantis
STLA
|
$33.7M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
$33.3M |
| 4 |
NetEase
NTES
|
$28.6M |
| 5 |
iShares China Large-Cap ETF
FXI
|
$27.1M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$263M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$115M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$108M |
| 4 |
UBS Group
UBS
|
$92.8M |
| 5 |
Logitech
LOGI
|
$31.8M |
Sector Composition
| 1 | Consumer Discretionary | 37.33% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 13% |
| 4 | Communication Services | 4.43% |
| 5 | Materials | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Savara
SVRA
$570M
| $30K | ﹤0.01% |
+10,847
| New | +$30K |
|
227
Precigen
PGEN
$1.39B
| $28.6K | ﹤0.01% |
+19,203
| New | +$28.6K |
|
228
Butterfly Network
BFLY
$388M
| $24.1K | ﹤0.01% |
+10,557
| New | +$24.1K |
|
229
Erasca
ERAS
$454M
| $23.4K | ﹤0.01% |
+17,067
| New | +$23.4K |
|
230
Sana Biotechnology
SANA
$716M
| $22.6K | ﹤0.01% |
+13,427
| New | +$22.6K |
|
231
Cerus
CERS
$243M
| $21.7K | ﹤0.01% |
+15,602
| New | +$21.7K |
|
|
UROY
232
Uranium Royalty Corp
UROY
$441M
| $21.6K | ﹤0.01% |
+12,245
| New | +$21.6K |
|
233
Allogene Therapeutics
ALLO
$253M
| $20.1K | ﹤0.01% |
+13,747
| New | +$20.1K |
|
234
Taysha Gene Therapies
TSHA
$777M
| $16.9K | ﹤0.01% |
+12,173
| New | +$16.9K |
|
235
Esperion Therapeutics
ESPR
$466M
| $16.4K | ﹤0.01% |
+11,411
| New | +$16.4K |
|
236
Quantum-Si Incorporated
QSI
$217M
| $12.7K | ﹤0.01% |
+10,624
| New | +$12.7K |
|
237
Tevogen Bio Holdings
TVGN
$177M
| $11.4K | ﹤0.01% |
+10,570
| New | +$11.4K |
|
238
Lexicon Pharmaceuticals
LXRX
$403M
| $10.9K | ﹤0.01% |
+23,712
| New | +$10.9K |
|
239
Apple
AAPL
$3.41T
| – | – |
-11,458
| Closed | -$2.87M |
|
240
Adtran
ADTN
$755M
| – | – |
-12,846
| Closed | -$107K |
|
241
Allstate
ALL
$53.4B
| – | – |
0
| – | – |
|
242
Advanced Micro Devices
AMD
$263B
| – | – |
-11,196
| Closed | -$1.35M |
|
243
Amazon
AMZN
$2.41T
| – | – |
-1,114
| Closed | -$244K |
|
244
Brookfield
BN
$99.4B
| – | – |
0
| – | – |
|
|
BORR
245
Borr Drilling
BORR
$793M
| – | – |
-259,008
| Closed | -$1.01M |
|
|
BPT
246
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| – | – |
0
| – | – |
|
247
B2Gold
BTG
$5.62B
| – | – |
0
| – | – |
|
248
Cullen/Frost Bankers
CFR
$8.31B
| – | – |
0
| – | – |
|
249
Global X Copper Miners ETF NEW
COPX
$2.08B
| – | – |
-49,666
| Closed | -$1.9M |
|
250
SPDR MSCI ACWI ex-US ETF
CWI
$1.95B
| – | – |
-18,000
| Closed | -$503K |
|